Anthony Kirck
Comptroller/Controller/Auditor en OPTINOSE, INC. .
Fortuna: 130 309 $ al 30/04/2024
Perfil
Anthony J.
Kirck's current job is Chief Accounting Officer, VP-Finance & Controller at OptiNose, Inc. His former jobs include Executive Director-Financial Planning & Analysis at Strongbridge Biopharma Plc from 2017 to 2020, and Controller at Verrica Pharmaceuticals, Inc. from 2020 to 2021.
He completed his undergraduate degree at Albright College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OPTINOSE, INC.
0.13% | 18/03/2024 | 143 988 ( 0.13% ) | 130 309 $ | 30/04/2024 |
Cargos activos de Anthony Kirck
| Empresas | Cargo | Inicio |
|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 01/11/2021 |
Antiguos cargos conocidos de Anthony Kirck.
| Empresas | Cargo | Fin |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01/11/2021 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 01/02/2020 |
Formación de Anthony Kirck.
| Albright College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Anthony Kirck